¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"passive transfer test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • pregnancy test
    ÀӽŰ˻ç
  • preservation test
    º¸Á¸½ÃÇè
  • presumptive test
    ÃßÁ¤½ÃÇè
  • prick test
    ´ÜÀÚ°Ë»ç, Â±â°Ë»ç
  • primed lymphocyte-typing test
    °¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
  • projective test
    Åõ»ç°Ë»ç
  • protection test
    ¹æ¾î½ÃÇè, ¿¹¹æÈ¿°ú°Ë»ç
  • provocation test
    À¯¹ß°Ë»ç, À¯¹ß¹ÝÀÀ°Ë»ç
  • pulmonary function test
    Æó±â´É°Ë»ç
  • test phantom
    Ç¥ÁظðÇü
  • qualitative test
    Á¤¼º°Ë»ç
  • quantitative test
    Á¤·®°Ë»ç
  • radiation sensitivity test
    ¹æ»ç¼±¹Î°¨µµ°Ë»ç
  • radioallergosorbent test
    ¹æ»ç¼±¾Ë·¹¸£±âÈíÂø°Ë»ç
  • radioimmuosorbent test
    ¹æ»ç¼±¸é¿ªÈíÂø°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • heat stability test
    ¿­¾ÈÁ¤¼º°Ë»ç
  • heat test
    ¿­½ÃÇè(ËçËàÌ´).
  • heat test
    ¿­½ÃÇè(æðãËúÐ).
  • heel knee test
    Á¾ºÎ ½½ °Ë»ç£¨ñ¢Ý»ã£ËþÞÛ£©£¬Á¾½½ ½ÃÇè(ñ¢ã£ãËúÐ).
  • heel tap test
    Á¾Å¸½ÃÇè(¡­ãËúÐ).
  • heel to knee to shin test
    Á¾½½°æ½ÃÇè<°Ë»ç> (ñ¢ã£ÌëãËúÐ<ËþÞÛ>).
  • hemadsorption test
    Ç÷±¸ÈíÂø°Ë»ç
  • hemagglutination inhibition test
    (Àû)Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý ÀúÁö½ÃÇè
  • hemagglutination inhibition test =HIT
    (Àû)Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè.
  • hemagglutination test
    (Àû)Ç÷±¸ÀÀÁý½ÃÇè
  • hemagglutination test
    Ç÷±¸ÀÀÁý¹ý
  • hemagglutination test
    Ç÷±¸ÀÀÁý °Ë»ç
  • hemagglutination test
    (Àû)Ç÷±¸ÀÀÁý½ÃÇè.
  • hemagglutination-inhibition (HI) test
    Ç÷±¸ÀÀÁý ÀúÁö½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • color form sorting test
    »öäÇüÅÂ(ßäóôû¡÷¾)Ã߸®±â °Ë»ç(ËþÞÛ)
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement fixation inhibition test
    º¸Ã¼°íÁ¤ÀúÇØ½ÃÇè(ÜÍô÷ͳïÒîÁúªãËúÐ).
  • complement fixation inhibition test
    º¸Ã¼°áÇÕÀúÇØ½ÃÇè(ÜÍô÷Ì¿ùêîÁúªãËúÐ).
  • complement fixation test
    º¸Ã¼°áÇÕ½ÃÇè
  • complement fixation test =CFT
    º¸Ã¼°íÁ¤½ÃÇè(¡­ãËúÐ).
  • complement fixation test =CFT
    º¸Ã¼°áÇÕ½ÃÇè(¡­ãËúÐ).
  • complement fixation test, indirect
    °£Á¢º¸Ã¼°áÇÕ½ÃÇè
  • comprehensive test of adaptive behavior
    Æ÷°ýÀû ÀûÀÀÇൿ°Ë»ç(øÐÎÀîÜ îêëëú¼ÔÑËþÞÛ).
  • confirmatory test
    È®ÀνÃÇè
  • confrontation field test
    ´ë¸é½Ã¾ß°Ë»ç
  • confrontation test
    ´ë¸é½Ã¾ß°Ë»ç (ãÊå¯ËþÞÛ)
  • constriction test
    ¾Ð¹Ú½ÃÇè(äâÚÞãËúÐ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
RNTMI transfer ribonucleic acid initiator methionine
RTF resistance transfer factor; respiratory tract fluid
SET surrogate embryo transfer; systolic ejection time
tDNA transfer deoxyribonucleic acid
TF free thyroxine; tactile fremitus; tail flick [reflex]; temperature factor; testicular feminization; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CAST Children of Alcoholics Screening Test
COPT Circumoval Precipitin Test
CDT Clock Drawing Test
CPT Cold Pressor Test
CWT Color Word Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Jaeger test
    ¿¹°Å ½ÃÇè
    °¡º±°Ô ¼Õ»ó½ÃŲ ºÎÀ§¿¡ ½Ã¾àÀ» ¹ß¶ó¼­ ÇǺÎÀÇ ¾Ë·¹¸£±â¸¦ ½ÃÇèÇÏ´Â ¹æ¹ý.
  • Jaeger's test type
    ¿¹°Å ¹®ÀÚ
    ½Ã·Â °Ë»ç¿¡ »ç¿ëµÇ´Â ´ë¼ÒÀÇ ¹®ÀÚ¸¦ ´Ã¾î³õÀº Ç¥.
  • Jaffe's test
    ¾ßÆä ½ÃÇè
    ÀεðÄ­ °ËÃâ¹ý.
  • Kahns test
    Ä­ ¸Åµ¶ Ç÷û °Ë»ç
    ¸Åµ¶ Ç÷ûÀÇ Ä§°­ ¹ÝÀÀÀ¸·Î, ºñµ¿È­µÈ ÇǰËÇ÷û 3cc·Î Èñ¼®ÇÑ Ç׿ø 0.05cc¸¦ °¡ÇØ, ÇÏ·ç ¹ãÀ» 37µµ·Î À¯ÁöÇÏ¿© ħÀüÀÌ ³ªÅ¸³ª¸é ¾ç¼º.
  • Kajdi's test
    Ä«À̵ð ½ÃÇè
    ±«Ç÷º´ Áø´Ü¿¡ ÀÌ¿ëµÇ´Â ½ÃÇèÀ¸·Î, ¾Æ½ºÄÚ¸£ºó»ê 200mgÀ» ±ÙÀ°ÁÖ»çÇϰí, 4½Ã°£ ÈÄ¿¡ Ç÷ÁßÀÇ ¾Æ½ºÄÚ¸£ºó»ê·®ÀÌ 0.2mg% ÀÌÇÏÀ̸é, ºñŸ¹Î C°¡ Æ÷È­¿¡ À̸£Áö ¾Ê¾Ò´Ù°í ÆÇÁ¤ÇÑ´Ù.
  • Kamnitzer's test
    °¨´Öó ½ÃÇè
    ÀӺο¡°Ô Ç÷θ®Áø 2.5mgÀ» Åõ¿©ÇÏ¸é ´ç´¢°¡ ¹ß»ýÇÏ´Â ¹ÝÀÀÀ» ÀÌ¿ëÇÑ ÀӽнÃÇè.
  • Kasanin-Vigotsky's test
    Ä«»ç´Ñ-ºñ°íÃ÷Ű ½ÃÇè
    ´ë³úÀÇ ±âÁú¼º Áúȯ°ú ºÐ¿­¼º »óŸ¦ ±¸º°Çϱâ À§ÇÑ ½ÃÇè.
  • Katayama's test
    īŸ¾ß¸¶ ½ÃÇè¹ý
    Ç÷¾× 5¹æ¿ï¿¡ ¹° 10¹æ¿ïÀ» °¡Çϰí, ´Ù½Ã ¿À·»Áö »öÀÇ È²È­ ¾Ï¸ð´Ï¾Æ 5¹æ¿ïÀ» °¡ÇÑ ´ÙÀ½ ÃÊ»êÀ¸·Î »ê¼ºÈ­ ÇÒ ¶§ ÀÏ»êȭź¼Ò°¡ ÀÖÀ¸¸é Àå¹Ì»ö, Á¤»ó Ç÷¾×ÀÌ¸é ¾Ï·Ï»öÀ» ³ªÅ¸³½´Ù.
  • Kathrein's test
    īƮ¶óÀÎ ½ÃÇè
    ÇÇ°Ë ´¢¿¡ 1% ¿ä¿Àµå ¾ËÄÚ¿Ã ¿ë¾×À» ÁßÃþÇϸé, ´ãÁó »ö¼Ò°¡ ÀÖÀ» ¶§´Â Á¢Ã˸鿡 ³ì»öÀÌ ³ªÅ¸³­´Ù.
  • keel knee test
    ½½Á¾ °Ë»ç
  • Kinberg's test
    Ųº£¸£Å© °Ë»ç
  • Knoop hardness test
    ´©ÇÁ °æµµ½ÃÇè
    Àç·áÀÇ °æµµ¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÇ ÇÑ °¡Áö. ¿ø¸®´Â ¾ÐÀÔ °æµµ ½ÃÇèÀÌ´Ù. ´ÉÇüÀÇ ´ë°¢¼±ÀÇ ºñ°¡ 7:11:1ÀÎ ´ÙÀ̾Ƹóµå ¾ÐÀÚ¸¦ »ç¿ëÇÏ¿© Á¤ÇÏÁßÀ» °¡ÇØ Àç·áÀÇ Ç¥¸é¿¡ ¾ÐÀÔÇÏ´Â °æµµ½ÃÇèÀÌ´Ù. ź¼º¿¡ ÀÇÇØ ȸº¹·ÂÀÌ ÀÖ´Â Àç·áÀÇ °æµµ ÃøÁ¤ÀÌ °¡´ÉÇϰí, ¶ÇÇÑ ¿¬¼ºÀÌ Å« Àç·á·ÎºÎÅÍ »ó´çÈ÷ ´Ü´ÜÇÑ Àç·á¿¡ À̸£±â±îÁö ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ¹Ç·Î, ´Ù¸¥ °ø¾÷ Àç·á¿¡ ºñÇØ ³ôÀº ź·Â¼ºÀ» °®´Â Ä¡°úÀç·áÀÇ °æµµ ÃøÁ¤ ½Ã¿¡ ³Î¸® ÀÌ¿ëµÈ´Ù.
  • Krimsky prism test
    Å©¸²½ºÅ° ÇÁ¸®Áò °Ë»ç
  • Kveim's test
    Å©¹ÙÀÓ ¹ÝÀÀ
  • laboratory test
    ½ÇÇè½Ç °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
chemotherapy drug sensitivity test <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful.
(16 Dec 1997)
Chick-Martin test A method of testing the in vitro efficiency of a bactericidal agent; a standard culture of Salmonella typhi which has been added to a fixed amount of sterilised faeces or yeast is tested for a fixed period (30 minutes), against various concentrations of phenol solution and various concentrations of the disinfectant; the result is expressed as a ratio: the phenol coefficient, which is the highest dilution of the disinfectant under test at which the bacteria are killed, divided by the highest dilution of phenol which sterilises the solution in the same length of time.
(05 Mar 2000)
chi-square test A statistical method of assessing the significance of a difference, as when the data from two or more samples is represented by a discrete number such as the numbers of females and males attending each of two colleges.
Synonym: x2 test.
(05 Mar 2000)
metabisulfite test A test for sickle cell haemoglobin (Hb S); deoxygenation of cells containing Hb S is enhanced by addition of sodium metabisulfite to the blood, causing sickling visible on a slide; certain other abnormal haemoglobins (Hb CHarlem and Hb I) also sickle in this test.
(05 Mar 2000)
Rickles test A colourimetric test for predicting dental caries activity by incubating saliva in sucrose and determining pH changes.
(05 Mar 2000)
Perls' test A test for haemosiderin, utilizing Perls' Prussian blue stain.
(05 Mar 2000)
Rimini's test A test for formaldehyde in urine, milk, and other fluids, by the use of dilute solution of phenylhydrazine hydrochloride, sodium nitroprusside, and sodium hydroxide.
(05 Mar 2000)
ring precipitin test A precipitin test in which antigen solution is carefully layered over antibody solution in a tube; as diffusion proceeds, a disk of precipitate forms where the antibody ratio is optimal.
Synonym: ring test.
(05 Mar 2000)
ring test A precipitin test in which antigen solution is carefully layered over antibody solution in a tube; as diffusion proceeds, a disk of precipitate forms where the antibody ratio is optimal.
Synonym: ring test.
(05 Mar 2000)
personality test Any of the category of psychological test's designed to test the characteristics of the personality, emotional status, mental disorder, etc., in contrast to an intelligence test.
(05 Mar 2000)
group test In psychology, a test designed to be administered to more than one individual at a time; e.g., scholastic achievement test, medical college admissions test.
(05 Mar 2000)
Rinne's test As a positive test: a vibrating tuning fork is held in contact with the skull (usually the mastoid process) until the sound is lost, its prongs are then brought close to the auditory orifice when, if the hearing is normal, a faint sound will again be heard, as a negative test: a vibrating tuning fork is heard longer and louder when in contact with the skull than when held near the auditory orifice, indicating some disorder of the sound conducting apparatus.
(05 Mar 2000)
Perthes' test A test for patency of deep femoral vein; with the patient standing, a tourniquet is applied above the knee; after walking, if deep circulation is competent, the superficial varicosities remain unchanged and legs become painful.
(05 Mar 2000)
growth hormone stimulation test <investigation> A test which measures the level of human growth hormone in response to the administration of the amino acid arginine. This test measures the ability of the pituitary gland to secrete growth hormone. Normal values in children are: 48 ng/ml. Normal values in men are 10 ng/ml. Normal values in women are 15 ng/ml. This test is used to evaluate infants with growth retardation. It may also be part of an evaluation for a pituitary tumour. Failure of arginine to raise growth hormone levels may indicate hypopituitarism or dwarfism.
(27 Sep 1997)
growth hormone suppression test <investigation> A test to determine if growth hormone is suppressed by hyperglycaemia. Growth hormone blood levels are determined sequentially after ingestion of a glucose-rich meal. If growth hormone levels remain elevated (after the glucose is given) then acromegaly or gigantism is suspected.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á